Request an Account
Physicians

For Physicians

Cytochrome P450 Genotyping

The CMM is offering physicians and their patients this FDA-approved microarray-based test to examine patient genotypes.

Results of this testing help determine how an individual will metabolize prescription drug options before they are prescribed. Available now, this CMM test can reduce or eliminate the possibility of potentially dangerous and costly adverse drug reactions and increase treatment efficiency by identifying favorable drugs options in advance.

The CMM is the only regional source for the CYP450 test, a cost-effective process that need only be conducted once to provide lifetime patient reference data for diagnosis and treatment . Physicians may contact the CMM directly to obtain more information and brochures describing the test. Patients are strongly encouraged to work with their physicians on the utility of this test in their healthcare management.

Specimen Requirements: 3-5 mL of blood collected in an EDTA (lavender cap) tube. Specimen must reach CMM within three days of collection. Do not freeze. Further details can be found below under Cytochrome P450 Genotyping Catalog Sheet.

Learn more here.

For a list of drugs metabolized by the Cytochrome P450 pathway, click here (PDF)

Download/View the Cytochrome P450 Genotyping Catalog Sheet (PDF)

Download/View the CMM Service Requisition Form (PDF)
(Only physicians may order this test.)

The charge for CYP450, $900, is not currently covered by insurance. Please contact us at 616.391.4330 or info@cmmdx.org for payment options.

Check back here and in the News for updates on our growing test menu. We welcome physician input on tests CMM should consider adding.